CGEN Q2 2025 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-81.2% YoY

Gross Profit

-$408,000-32.5% margin

Operating Income

-$8M-670.6% margin

Net Income

-$7M-584.1% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-45.0%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$107M

Total Liabilities

$56M

Stockholders' Equity

$50M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$7M	-81.2%
Gross Profit	-$408,000	$5M	-107.9%
Operating Income	-$8M	-$3M	-147.0%
Net Income	-$7M	-$2M	-245.8%